PT  - JOURNAL ARTICLE
AU  - Priestley-Milianta, Christopher
TI  - 825 α-CD38 therapy reverses α-PD1 resistance when used in a proper biologic schedule; explaining and overcoming previous failures of the combination in clinical trials
AID  - 10.1136/jitc-2023-SITC2023.0825
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A923--A923
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A923.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A923.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.